AI assistant
CASTLE BIOSCIENCES INC — Director's Dealing 2023
Sep 1, 2023
32601_dirs_2023-09-01_8f0d1821-8a47-408d-9e4d-ca9cf6b65c9d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2023-08-30
Reporting Person: BRADBURY DANIEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-30 | Common Stock | S | 2780 | $20.03 | Disposed | 106759 | Indirect |
| 2023-08-30 | Common Stock | S | 926 | $20.03 | Disposed | 66854 | Indirect |
| 2023-08-30 | Common Stock | S | 926 | $20.03 | Disposed | 66879 | Indirect |
| 2023-08-31 | Common Stock | S | 4372 | $20.053 | Disposed | 102387 | Indirect |
| 2023-08-31 | Common Stock | S | 1457 | $20.053 | Disposed | 65397 | Indirect |
| 2023-08-31 | Common Stock | S | 1457 | $20.053 | Disposed | 65422 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4655 | Direct |
Footnotes
F1: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on November 23, 2022.
F2: This transaction was executed in multiple trades at prices ranging from $20.000 to $20.075, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F5: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F6: This transaction was executed in multiple trades at prices ranging from $20.000 to $20.135, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.